Surgical management of primary hyperparathyroidixsm

Hiroshi Takami, Y. Ikeda, Norihito Wada

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Bilateral neck explorations for primary hyperparathyroidism have a high cure rate (> 95%) and a low rate of morbidity when performed by experienced surgeons. Despite this, there have been many efforts to minimize the procedure in terms of length and region of incision, cost, extent of exploration, and length of hospital stay, while maintaining an excellent outcome. A renewed interest in unilateral neck exploration for primary hyperparathyroidism developed upon the introduction of sestamibi scintigrams as a new preoperative localization technique. The localization of adenomas using this technique was much more accurate than that of previous localization studies, allowing unilateral procedures to become feasible. Several surgeons have advocated a unilateral approach using preoperative sestamibi scanning. Sestamibi-guided parathyroidectomies enable parathyroidectomies to be performed much more rapidly through a significantly less invasive dissection. This procedure results in a very high cure rate with fewer complications, a smaller neck incision, and less use of postoperative narcotics. In patients with hyperparathyroidism, the intraoperative quick PTH assay allows the success of the procedure to be predicted intraoperatively. The intraoperative quick PTH assay is not only helpful in standard initial parathyroidectomies, but also improves the success rate of reoperative procedures. Its use is mandatory in all minimally invasive procedures. Initial reports regarding this innovation have been extremely positive. Nevertheless, some questions have been raised regarding the accuracy and utility of this procedure. Endoscopic parathyroidectomies offer several opportunities for innovation. Various approaches have been shown to be technically feasible, such as endoscopic procedures that rely on CO2 insufflation to create a working space or video-assisted procedures in which the working space is maintained through conventional external retraction. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

Original languageEnglish
JournalBiomedicine and Pharmacotherapy
Volume54
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2000 Jun
Externally publishedYes

Fingerprint

Parathyroidectomy
Neck
Primary Hyperparathyroidism
Length of Stay
Insufflation
Hyperparathyroidism
Narcotics
Adenoma
Dissection
Morbidity
Costs and Cost Analysis
Surgeons

Keywords

  • Minimal invasive parathyroidectomy
  • Parathyroideetomy
  • Primary hyperparathyroidism

ASJC Scopus subject areas

  • Pharmacology

Cite this

Surgical management of primary hyperparathyroidixsm. / Takami, Hiroshi; Ikeda, Y.; Wada, Norihito.

In: Biomedicine and Pharmacotherapy, Vol. 54, No. SUPPL. 1, 06.2000.

Research output: Contribution to journalArticle

Takami, Hiroshi ; Ikeda, Y. ; Wada, Norihito. / Surgical management of primary hyperparathyroidixsm. In: Biomedicine and Pharmacotherapy. 2000 ; Vol. 54, No. SUPPL. 1.
@article{0942f52cc65f4a378bf3622f1990338c,
title = "Surgical management of primary hyperparathyroidixsm",
abstract = "Bilateral neck explorations for primary hyperparathyroidism have a high cure rate (> 95{\%}) and a low rate of morbidity when performed by experienced surgeons. Despite this, there have been many efforts to minimize the procedure in terms of length and region of incision, cost, extent of exploration, and length of hospital stay, while maintaining an excellent outcome. A renewed interest in unilateral neck exploration for primary hyperparathyroidism developed upon the introduction of sestamibi scintigrams as a new preoperative localization technique. The localization of adenomas using this technique was much more accurate than that of previous localization studies, allowing unilateral procedures to become feasible. Several surgeons have advocated a unilateral approach using preoperative sestamibi scanning. Sestamibi-guided parathyroidectomies enable parathyroidectomies to be performed much more rapidly through a significantly less invasive dissection. This procedure results in a very high cure rate with fewer complications, a smaller neck incision, and less use of postoperative narcotics. In patients with hyperparathyroidism, the intraoperative quick PTH assay allows the success of the procedure to be predicted intraoperatively. The intraoperative quick PTH assay is not only helpful in standard initial parathyroidectomies, but also improves the success rate of reoperative procedures. Its use is mandatory in all minimally invasive procedures. Initial reports regarding this innovation have been extremely positive. Nevertheless, some questions have been raised regarding the accuracy and utility of this procedure. Endoscopic parathyroidectomies offer several opportunities for innovation. Various approaches have been shown to be technically feasible, such as endoscopic procedures that rely on CO2 insufflation to create a working space or video-assisted procedures in which the working space is maintained through conventional external retraction. (C) 2000 Editions scientifiques et medicales Elsevier SAS.",
keywords = "Minimal invasive parathyroidectomy, Parathyroideetomy, Primary hyperparathyroidism",
author = "Hiroshi Takami and Y. Ikeda and Norihito Wada",
year = "2000",
month = "6",
doi = "10.1016/S0753-3322(00)80005-0",
language = "English",
volume = "54",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Surgical management of primary hyperparathyroidixsm

AU - Takami, Hiroshi

AU - Ikeda, Y.

AU - Wada, Norihito

PY - 2000/6

Y1 - 2000/6

N2 - Bilateral neck explorations for primary hyperparathyroidism have a high cure rate (> 95%) and a low rate of morbidity when performed by experienced surgeons. Despite this, there have been many efforts to minimize the procedure in terms of length and region of incision, cost, extent of exploration, and length of hospital stay, while maintaining an excellent outcome. A renewed interest in unilateral neck exploration for primary hyperparathyroidism developed upon the introduction of sestamibi scintigrams as a new preoperative localization technique. The localization of adenomas using this technique was much more accurate than that of previous localization studies, allowing unilateral procedures to become feasible. Several surgeons have advocated a unilateral approach using preoperative sestamibi scanning. Sestamibi-guided parathyroidectomies enable parathyroidectomies to be performed much more rapidly through a significantly less invasive dissection. This procedure results in a very high cure rate with fewer complications, a smaller neck incision, and less use of postoperative narcotics. In patients with hyperparathyroidism, the intraoperative quick PTH assay allows the success of the procedure to be predicted intraoperatively. The intraoperative quick PTH assay is not only helpful in standard initial parathyroidectomies, but also improves the success rate of reoperative procedures. Its use is mandatory in all minimally invasive procedures. Initial reports regarding this innovation have been extremely positive. Nevertheless, some questions have been raised regarding the accuracy and utility of this procedure. Endoscopic parathyroidectomies offer several opportunities for innovation. Various approaches have been shown to be technically feasible, such as endoscopic procedures that rely on CO2 insufflation to create a working space or video-assisted procedures in which the working space is maintained through conventional external retraction. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

AB - Bilateral neck explorations for primary hyperparathyroidism have a high cure rate (> 95%) and a low rate of morbidity when performed by experienced surgeons. Despite this, there have been many efforts to minimize the procedure in terms of length and region of incision, cost, extent of exploration, and length of hospital stay, while maintaining an excellent outcome. A renewed interest in unilateral neck exploration for primary hyperparathyroidism developed upon the introduction of sestamibi scintigrams as a new preoperative localization technique. The localization of adenomas using this technique was much more accurate than that of previous localization studies, allowing unilateral procedures to become feasible. Several surgeons have advocated a unilateral approach using preoperative sestamibi scanning. Sestamibi-guided parathyroidectomies enable parathyroidectomies to be performed much more rapidly through a significantly less invasive dissection. This procedure results in a very high cure rate with fewer complications, a smaller neck incision, and less use of postoperative narcotics. In patients with hyperparathyroidism, the intraoperative quick PTH assay allows the success of the procedure to be predicted intraoperatively. The intraoperative quick PTH assay is not only helpful in standard initial parathyroidectomies, but also improves the success rate of reoperative procedures. Its use is mandatory in all minimally invasive procedures. Initial reports regarding this innovation have been extremely positive. Nevertheless, some questions have been raised regarding the accuracy and utility of this procedure. Endoscopic parathyroidectomies offer several opportunities for innovation. Various approaches have been shown to be technically feasible, such as endoscopic procedures that rely on CO2 insufflation to create a working space or video-assisted procedures in which the working space is maintained through conventional external retraction. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

KW - Minimal invasive parathyroidectomy

KW - Parathyroideetomy

KW - Primary hyperparathyroidism

UR - http://www.scopus.com/inward/record.url?scp=0033945072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033945072&partnerID=8YFLogxK

U2 - 10.1016/S0753-3322(00)80005-0

DO - 10.1016/S0753-3322(00)80005-0

M3 - Article

C2 - 10914985

AN - SCOPUS:0033945072

VL - 54

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - SUPPL. 1

ER -